A Food and Drug Administration advisory panel voted to broaden access to at least one peptide during a two-day meeting discussing whether compounding pharmacies can fill prescriptions for some unapproved peptides. The meeting comes during a surge of interest in the unapproved therapies. Peptides are short strings of amino acids, the building blocks of proteins, linked by…
The FDA is convening an advisory committee over the next two days to discuss whether compounding pharmacies can dispense seven unapproved peptides with a doctor’s prescription for special medical conditions. Some health experts are skeptical because of the lack of research. Adam Yamaguchi reports. Source link
The Trump administration is forging ahead with a controversial plan to collect the medical records of millions of federal workers and retirees, as well as their family members. The Office of Personnel Management said in a notice posted last month that it will begin routinely collecting identifiable, personal health information on more than 8 million…
